Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark, March 26, 2026. Tom...
Stanley Druckenmiller at CNBC's Delivering Alpha on Sept. 28, 2022.Scott Mlyn | CNBCA version of this article first appeared in CNBC's Inside Wealth newsletter...
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...